OGOlga I. Gumeniuk

Olga I. Gumeniuk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olga I. Gumeniuk has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • PULMONARY EPITHELIOID HEMANGIOENDOTHELIOMA IN AN ADOLESCENT: A CLINICAL CASE

    by Yu.V. Chernenkov, O.I. Gumeniuk, E.V. Balashova, I.V. Goremykin, I.S. Davydov, E.V. Deeva, M.S. Kubirov, G.N. Maslyakova, A.E. Paltseva, E.R. Rogacheva, et al.

    Pulmonary epithelioid hemangioendothelioma (PEH) is a rare vascular neoplasm of intermediate malignancy characterized by a highly variable clinical course and significant diagnostic challenges. In pediatric practice, the incidence of this condition is extremely low, which often leads to diagnostic errors, particularly in cases with atypical molecular variants. Objective: To demonstrate the clinical, instrumental, and morphological features of pulmonary epithelioid hemangioendothelioma in children and to highlight the challenges of differential diagnosis. Materials and Methods: We present a clinical case of a 14-year-old adolescent with bilateral diffuse lung involvement who underwent a comprehensive diagnostic evaluation, including chest computed tomography, bronchoscopy with biopsy, histological and immunohistochemical analysis, as well as lung function testing. Results: Multiple bilateral pulmonary nodules were identified, while no significant functional impairment was observed. The initial histological findings were consistent with organizing pneumonia. The differential diagnosis included tuberculosis, sarcoidosis, pulmonary alveolar proteinosis, and IgG4-related lung disease. The final diagnosis was established after expert histopathological review, revealing features of PEH with positive expression of endothelial markers (CD31, CD34, ERG) and absence of CAMTA1 and TFE3 expression. This pattern does not correspond to the typical molecular variants observed in the majority of cases and underscores the molecular heterogeneity of the tumor. Conclusion: This case demonstrates that PEH may mimic inflammatory lung diseases and be associated with negative results for key molecular markers (CAMTA1, TFE3). Accurate diagnosis requires a comprehensive approach, including detailed histological and immunohistochemical evaluation. Awareness of this entity in the differential diagnosis of diffuse lung diseases in children may reduce the risk of diagnostic errors and highlights the importance of a multidisciplinary approach involving pediatricians, pulmonologists, oncologists, and pathologists.

  • Gastrointestinal manifestations and eating behavior in autism spectrum disorder: the role of sensory dysfunction and intestinal microbiota

    by M. E. Lobanov, O. I. Gumenyuk, Yu. V. Chernenkov, A. V. Vorozhtsova

    Eating disorders and gastrointestinal manifestations are widespread in children with autism spectrum disorders (ASD), but they remain heterogeneous in clinical manifestations and mechanisms of formation. This review summarizes current data on the role of sensory dysfunction and intestinal microbiota in the formation of eating behavior and gastrointestinal symptoms in ASD. It has been shown that sensory phenotypes, primarily sensory avoidance and sensory search for stimuli, are key determinants of nutritional selectivity, dietary structure, and the nature of gastrointestinal complaints. The pathophysiological foundations of the brain-gut-microbiota axis are considered, including changes in the microbiota profile, impaired intestinal barrier function, and signs of chronic low-level inflammation, which may enhance innate sensory features and contribute to the consolidation of pathological eating patterns in certain subgroups of children with ASD. Special attention is paid to the genetic and epigenetic mechanisms affecting sensory processing, receptor sensitivity, and appetite regulation, which partially explains the high interindividual variability of clinical manifestations and the heterogeneous effectiveness of standard dietary interventions. The need for a phenotypically oriented approach to the assessment of nutritional and gastrointestinal disorders in ASD is emphasized, based on a comprehensive analysis of sensory characteristics, eating behavior and the state of the gastrointestinal tract.

  • Open Access

    Nutritional characteristics of children with autism spectrum disorder

    by M. E. Lobanov, O. I. Gumenyuk, Yu. V. Chernenkov

    Nutritional characteristics of children with autism spectrum disorder | Lobanov | Experimental and Clinical Gastroenterology Особенности питания у детей с расстройством аутистического спектра | Лобанов | Экспериментальная и клиническая гастроэнтерология

  • Compound heterozygosity as a cause of diagnostic difficulties in patients with hereditary diseases

    by M. E. Lobanov, O. I. Gumenyuk, Yu. V. Chernenkov, O. S. Groznova, Z. G. Afaunova, P. D. Polyakova, M. A. Sukhanova, R. A. Kapyov, D. N. Shemirzov, L. M. Shipilova

    Background . Up to 40 % of patients with suspected monogenic disorders remain undiagnosed when using targeted gene panels or exome sequencing, particularly in cases of compound heterozygosity where one pathogenic variant goes undetected. The aim . To investigate the molecular and clinical features of compound heterozygous conditions in children with suspected inherited diseases and to evaluate the diagnostic utility of whole genome sequencing (WGS). Materials and methods . A prospective observational study was conducted between 2023 and 2025. The study included 7 pediatric patients (under 18 years old) with suspected genetic disorders in whom previous genetic testing identified only a single pathogenic variant. All patients underwent WGS followed by bioinformatic analysis and variant interpretation according to ACMG-AMP (2015) guidelines. No medical interventions were performed. The primary endpoint was the identification and phenotypic correlation of compound heterozygous mutations. Results . Compound heterozygous mutations were identified in all patients, totaling 14 variants across 7 genes (PAH, GALT, DNAH5, CHRNA3, SLC26A2, LAMA2, IDUA). Fifty percent of the variants had not been previously reported. Five patients had variants of uncertain significance (VUS) that followed by syndromic clinical presentations. WGS enabled confirmation of the diagnosis, refinement of the genotypic profile, adjustment of clinical management strategies, and improved diagnostic precision. No adverse events related to diagnostic procedures were observed. Conclusion . Whole genome sequencing demonstrated high diagnostic value in identifying compound heterozygous mutations, especially in cases where standard methods failed to detect the second variant. The detection of previously unreported mutations and clinically correlated VUS highlights the necessity of integrating WGS into routine pediatric genetic diagnostics.

  • Open Access

    Precision gastroenterology in pediatrics: CYP2C19 and individual metabolism of proton pump inhibitors in children with autism spectrum disorder

    by O. I. Gumenyuk, M. E. Lobanov, Yu. V. Chernenkov, O. S. Groznova, A. V. Vorozhtsova, S. V. Balashova

    The aim of this study was to investigate the pharmacogenetic characteristics of proton pump inhibitors (PPIs) metabolism in children with autism spectrum disorder (ASD) based on whole-genome sequencing data and pharmacogenetic testing. A retrospective cross-sectional analysis was conducted involving 31 children with ASD aged 3 to 18 years. CYP2C19 genotyping was performed, assessing allele distribution and metabolic phenotypes using international databases such as CPIC and PharmGKB. The results revealed a high frequency of the CYP2C19*17 allele, associated with rapid PPI metabolism, in 32% of participants, notably higher (42%) in the subgroup with genetic syndromes. The CYP2C19*2 allele, linked to slow metabolism, was not detected. The CYP2C19*17 allele showed an even gender distribution. These findings indicate significant genetic heterogeneity in PPI metabolism among children with ASD, impacting the clinical efficacy of therapy. The data emphasize the necessity of pharmacogenetic testing to personalize PPI dosing and improve treatment outcomes for gastrointestinal disorders in this patient population. The absence of the CYP2C19*2 allele warrants further investigation. Integrating genetic information into clinical protocols supports the advancement of precision medicine and enhances the quality of life for children with ASD.

  • Open Access

    Features of the course of the early period of primary tuberculosis infection in a patient with Hurler syndrome: tactics of managing a comorbid patient

    by I. A. Glushakov, M. E. Lozovskaya, O. I. Gumeniuk

    A clinical case of a child with comorbid pathology demonstrates the high importance of alertness of specialists of various profiles of the pediatric network. Doctors of the pediatric phthisiology network are of no small importance, since in children with genetic diseases, tuberculosis can proceed under the «masks» of other pathologies. Mucopolysaccharidosis type I (MPS I) is a rare genetic disease caused by a mutation of the IDUA gene, which encodes the enzyme alpha-L-iduronidase. Hurler syndrome, which is the most severe form of MPS I, requires special attention to prevent the development of severe complications, which often lead to death.

  • Integrated approach to care of children with genetic disorders on the example of a child with A pert syndrome (clinical case)

    by Igor A. Glushakov, Olga I. Gumenyuk, Darya A. Tyapkina, Gadzhikerim E. Gadzhikerimov, Yuri V. Chernenkov

    The article presents a clinical case of Apert syndrome in a 2-year-old child. Apert syndrome is an auto-somal dominant hereditary craniosynostosis that develops due to the pathogenic variant of the FGFR2 gene, which leads to a deficiency of intracellular signals that regulate embryogenesis, causing premature gastrulation, implantation abnormalities, violation of epithelial-mesenchymal interactions, which determines the severity of the patient's condition. The article demonstrates an integrated approach to the management and observation of such a patient with the involvement of specialists of various profiles.

  • Open Access

    Damage to the digestive tract and connective tissue dysplasia

    by Z. K. Azizova, P. E. Eremenkova, Yu. V. Chernenkov, O. I. Gumeniuk

    Introduction. Connective tissue (CT) forms the structural and functional basis of all organ systems in the human body, including the gastrointestinal (GI) tract. Congenital CT disorders, commonly referred to as connective tissue dysplasia (CTD), result from mutations in genes encoding extracellular matrix proteins. CTD includes both differentiated forms, such as Marfan syndrome and Ehlers-Danlos syndrome, and undifferentiated CTD (UCTD), which lacks a specific clinical pattern. UCTD is highly prevalent, affecting up to 20% of the population, and is associated with GI disorders in more than 69% of pediatric cases. Methods. A literature review was conducted to evaluate the impact of CTD on the GI tract, focusing on anatomical abnormalities, motor disturbances, inflammation, microbiota alterations, and associated complications. Clinical data on structural changes, dysmotility syndromes, and comorbidities were analyzed. Results. CTD leads to a wide spectrum of gastrointestinal abnormalities, including motor and tonic dysfunction, sphincter weakness, and various types of reflux (gastroesophageal, duodenogastric, biliary-pancreatic). Structural anomalies of the oral cavity (e. g., high-arched palate, malocclusion, macroglossia) impair food processing and increase digestive load. Visceroptosis and elongation of hollow organs (dolichosigmoid, megacolon, elongated gallbladder) result in impaired motility and stagnation, promoting diverticulosis and chronic inflammation. CTD is associated with a higher incidence of inflammatory diseases of the upper GI tract (esophagitis, gastritis, duodenitis), dysbiosis, and atypical peptic ulcers. Gastrointestinal manifestations also include a more severe course of irritable bowel syndrome and celiac disease, with increased visceral hypersensitivity, dysmotility, and persistent intestinal inflammation. Discussion. CTD predisposes individuals to polymorphic GI pathology, with a distinctive clinical course and complications. Underlying mechanisms involve autonomic dysfunction, impaired collagen synthesis, reduced smooth muscle tone, and structural disorganization of the extracellular matrix. Given the prevalence and systemic nature of UCTD, early recognition and stratification of at-risk patients are essential for individualized preventive and therapeutic strategies. Conclusion. Connective tissue dysplasia significantly influences gastrointestinal health, contributing to the development and progression of various digestive disorders. Recognizing patients with both differentiated and undifferentiated forms of CTD is crucial for timely diagnosis and for optimizing management plans to reduce complications and improve outcomes.


  • Open Access

    Eating disorders in children with autism spectrum disorder: genetic aspects

    by O. I. Gumenyuk, M. E. Lobanov, Yu. V. Chernenkov, O. S. Groznova, R. S. Kurbanov, A. A. Rubtsov, A. M. Avakyan, I. A. Alimagomedov, M. A. Abdullayev

    Autism spectrum disorder (ASD) is a group of disorders with inherent problems in social communication and stereotypical behaviour, often accompanied by various comorbidities. Eating disorders are one of the most common but often neglected problems in children with ASD occurring in 51-89% of children with the disorder. This study analysed genetic factors associated with eating disorders in children with ASD using a whole-genome sequencing and a Sanger sequencing in a sample of 28 children. Pathogenic mutations in several genes such as ANKRD11, ARID1B and UBE3A, which affect neuroplasticity and sensory perception, were identified. The results of the study emphasize the link between eating disorders in ASD and genetic mutations. Understanding these genetic factors may lead to the development of more effective treatments and management of eating disorders allowing for a personalised approach to the therapy. This study confirms the importance of the incorporating genetic testing into a clinical practice to better predict and improve the quality of life of children with ASD.

  • Open Access

    Comorbid conditions in Gilbert’s syndrome in children

    by A. I. Batdalova, К. Ф. Ильдаров, T. M. Batchaeva, D. V. Ovakimian, Yu. V. Chernenkov, O. I. Gumeniuk

    The study of comorbid pathology in Gilbert’s syndrome is an important area in medical genetics and pediatrics. An important feature of Gilbert’s syndrome is that its clinical manifestations can vary from an asymptomatic course to the appearance of a number of comorbid conditions, such as diseases of the gastrointestinal tract and the biliary system. Its study makes it possible to better understand the mechanism of development of these conditions, to develop effective diagnostic and therapeutic approaches.